DK673489A - Overtrukne klaebetabletter - Google Patents

Overtrukne klaebetabletter Download PDF

Info

Publication number
DK673489A
DK673489A DK673489A DK673489A DK673489A DK 673489 A DK673489 A DK 673489A DK 673489 A DK673489 A DK 673489A DK 673489 A DK673489 A DK 673489A DK 673489 A DK673489 A DK 673489A
Authority
DK
Denmark
Prior art keywords
clause
tablets
covered
covered clause
clause tablets
Prior art date
Application number
DK673489A
Other languages
English (en)
Other versions
DK673489D0 (da
Inventor
Satisc Chandra Khanna
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK673489D0 publication Critical patent/DK673489D0/da
Publication of DK673489A publication Critical patent/DK673489A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK673489A 1988-12-30 1989-12-29 Overtrukne klaebetabletter DK673489A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH485588 1988-12-30

Publications (2)

Publication Number Publication Date
DK673489D0 DK673489D0 (da) 1989-12-29
DK673489A true DK673489A (da) 1990-07-01

Family

ID=4283720

Family Applications (1)

Application Number Title Priority Date Filing Date
DK673489A DK673489A (da) 1988-12-30 1989-12-29 Overtrukne klaebetabletter

Country Status (12)

Country Link
US (1) US5091184A (da)
EP (1) EP0376891A1 (da)
JP (1) JPH02221219A (da)
KR (1) KR900009071A (da)
AU (1) AU628455B2 (da)
CA (1) CA2006771A1 (da)
DK (1) DK673489A (da)
IL (1) IL92863A0 (da)
NZ (1) NZ231923A (da)
PH (1) PH26730A (da)
PT (1) PT92730A (da)
ZA (1) ZA899947B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284659A (en) * 1990-03-30 1994-02-08 Cherukuri Subraman R Encapsulated flavor with bioadhesive character in pressed mints and confections
TW209174B (da) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
US5525519A (en) * 1992-01-07 1996-06-11 Middlesex Sciences, Inc. Method for isolating biomolecules from a biological sample with linear polymers
GB9308430D0 (en) * 1993-04-23 1993-06-09 Glaxo Group Ltd Medicaments
FR2742989B1 (fr) * 1995-12-29 1998-01-23 Adir Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs
DE19600324A1 (de) 1996-01-08 1997-07-10 Basf Ag Granulate für kosmetische und pharmazeutische Zubereitungen
ID26395A (id) * 1998-05-15 2000-12-21 Warner Lambert Comapny Turunan asam gamma-aminobutirat yang mengandung komposisi padat dan proses pembuatannya
CA2327285C (en) 1998-05-15 2005-06-14 Warner-Lambert Company Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
FR2798289B1 (fr) * 1999-09-15 2004-12-31 Cll Pharma Formes galeniques a delitement rapide en bouche et leur procede de preparation
MXPA03011096A (es) * 2001-05-29 2004-12-06 Depomed Dev Ltd Metodo para el tratamiento de la enfermedad de reflujo gastroesofagico y la saturacion acida nocturna.
US7186855B2 (en) * 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
CA2449729C (en) * 2001-06-11 2009-11-03 Xenoport, Inc. Prodrugs of gaba analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) * 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
RU2325152C2 (ru) * 2001-07-04 2008-05-27 Сан Фармасьютикл Индастриз Лимитид Удерживаемая в желудке система регулируемой доставки лекарственного средства
US6620900B2 (en) * 2002-02-07 2003-09-16 Isp Investments Inc. Proliferous copolymer of vinyl pyrrolidone and vinyl acetate
US20030175342A1 (en) * 2002-03-14 2003-09-18 Karl Kolter Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
EP2354120A1 (en) 2003-08-20 2011-08-10 XenoPort, Inc. Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
BRPI0413756A (pt) * 2003-08-20 2006-10-31 Xenoport Inc composto, métodos para tratar ou evitar espasticidade ou um sintoma de espasticidade, doença de refluxo gastro-esofágico, vìcio em droga, vìcio em ou abuso de álcool, ou vìcio em ou abuso de nicotina, e tosse ou êmese em um paciente, e, composição farmacêutica
US20050220863A1 (en) * 2004-04-02 2005-10-06 Chien-Hsuan Han Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
US20050220873A1 (en) * 2004-04-02 2005-10-06 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist
US20050226927A1 (en) * 2004-04-02 2005-10-13 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist
US7494985B2 (en) * 2004-11-03 2009-02-24 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
US7566738B2 (en) * 2004-11-03 2009-07-28 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
MX2007005306A (es) * 2004-11-04 2007-06-11 Xenoport Inc Formas de dosis oral de liberacion sostenida de la prodroga gabapentina.
AU2007201808B8 (en) * 2006-04-26 2013-09-05 Sun Pharmaceutical Advanced Research Company Ltd A method for alleviating signs and symptoms of spasticity
US7585996B2 (en) * 2006-09-15 2009-09-08 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
GB201319792D0 (en) * 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
JP6716582B2 (ja) 2014-11-07 2020-07-01 サブリミティ・セラピューティクス・リミテッドＳｕｂｌｉｍｉｔｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ シクロスポリンを含む組成物
EP3244884A4 (en) 2015-01-15 2018-07-25 Allaysis, LLC Intravenous baclofen formulations and treatment methods
EP3347004A4 (en) * 2015-10-21 2019-06-05 Allaysis, LLC INTRAVENOUS BACLOFEN AND METHODS OF TREATMENT
JP2023551954A (ja) * 2020-12-04 2023-12-13 インビクタス バイオテクノロジー プロプライエタリー リミテッド トコトリエノールの経粘膜送達

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1288725A (fr) * 1959-02-18 1962-03-30 Abbott Lab Procédé pour appliquer un revêtement aux comprimés et analogues, composition d'enduit à base de cire souple soluble et de copolymère polyvinylpyrrolidoneacétate de vinyle pour former ledit revêtement, et comprimés et analogues ainsi obtenus
US3972995A (en) * 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
NL7706429A (nl) * 1977-06-10 1978-12-12 Univ Erasmus Werkwijze voor de bereiding van een geneesmid- del met angst en angstequivalenten opheffende werking en gevormd geneesmiddel met een derge- lijke werking.
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
JPH0729915B2 (ja) * 1986-02-01 1995-04-05 帝國製薬株式会社 シ−ト状口腔内貼付剤
GB8608818D0 (en) * 1986-04-11 1986-05-14 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
US4900552A (en) * 1988-03-30 1990-02-13 Watson Laboratories, Inc. Mucoadhesive buccal dosage forms

Also Published As

Publication number Publication date
CA2006771A1 (en) 1990-06-30
ZA899947B (en) 1990-08-29
PH26730A (en) 1992-09-28
AU628455B2 (en) 1992-09-17
DK673489D0 (da) 1989-12-29
NZ231923A (en) 1992-03-26
JPH02221219A (ja) 1990-09-04
KR900009071A (ko) 1990-07-02
IL92863A0 (en) 1990-09-17
EP0376891A1 (de) 1990-07-04
US5091184A (en) 1992-02-25
AU4717789A (en) 1990-07-05
PT92730A (pt) 1990-07-31

Similar Documents

Publication Publication Date Title
DK673489D0 (da) Overtrukne klaebetabletter
ES2012750A4 (es) Conjunto recipiente-aplicador
DK229489A (da) Laegemiddeladsorbater
ATA901789A (de) Somatostatinpeptid
BR8806093A (pt) Trepano
ATA900689A (de) Calcitoninpeptide
ATA172889A (de) Furanderivate
DK233789A (da) Filmcoated tablet
FI893835A7 (fi) Lääkkeitä
DE68926597D1 (de) Mikrorechner
FI91488B (fi) Seula
BR8902098A (pt) Eletrolisador
DK113291D0 (da) Homogent enzymimmunassay
DK137889D0 (da) Foldeaeske
BR8906898A (pt) Jamela
DK182290A (da) Foldeaeske
DE68926367D1 (de) Hydroxymethylcyclobutylpurine
ATA296888A (de) Labyrinthanordnung
KR890017257U (ko) 팽 이
KR890023207U (ko) 관계수
DD277186A3 (de) Waelzlagerseparator
SE8800664D0 (sv) Sikt
IT216207Z2 (it) Taglia tigella
BR6800600U (pt) Hidro-serra
BR6802550U (pt) Bicicleta-skate

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment